SERA
SERA PROGNOSTICS, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.09
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 91.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.39x
- Price / sales
- 1175.03x
- Price / cash flow
- -2.97x
Enterprise value
- Enterprise value
- $38.8M
- EV / sales
- 554.40x
- EV / EBITDA
- -1.20x
- EV / EBIT
- -1.04x
- Market cap
- $82.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026